thanassisantonopoulos

19/04/2026

❤️ Cardiomiopatia aritmogena: al via un nuovo progetto di ricerca.

Con 570 mila euro dal Ministero della Salute, studiamo una delle principali cause di morte improvvisa negli sportivi. L’obiettivo è migliorare diagnosi precoce, valutazione del rischio e gestione clinica, anche in relazione all’attività fisica.

Il progetto coinvolge le UOC di Patologia Cardiovascolare e Cardiologia dell’Azienda Ospedale-Università Padova, insieme alla UOC di Medicina dello Sport dell’Ulss 2 Marca trevigiana.
> unipd.link/progetto-cardiomiopatia-sport

❤️ Arrhythmogenic cardiomyopathy: a new research project gets underway.

With €570,000 in funding from the Italian Ministry of Health, we are studying one of the leading causes of sudden death in athletes. The goal is to improve early diagnosis, risk assessment, and clinical management, also in relation to physical activity.

The project involves the Cardiovascular Pathology and Cardiology UOC of the University Hospital of Padua, together with the UOC of Sports Medicine of ULSS 2 Treviso.
> unipd.link/progetto-cardiomiopatia-sport-eng

19/04/2026

05/04/2026

🫀 SPIRIT-HF at : Spironolactone, an aldosterone blocker, compared with placebo, did not show any significant improvement in terms of HF hospitalizations and cardiovascular death at 24 months in patients with or .

See the results ➡️ https://bit.ly/4cbiPeW

05/04/2026

In symptomatic moderate AS, the stress aortic valve index (SAVI) identifies a high-risk subgroup not captured by conventional metrics and independently predicts the need for valve intervention (HR 5.7).

https://eurointervention.pcronline.com/article/clinical-outcomes-and-haemodynamic-response-after-blinded-stress-assessment-of-moderate-aortic-stenosis

14/03/2026

A CHEST Special Features article explores the past, present, and future of intrapleural fibrinolytic therapy.

Read more in the February issue of the journal CHEST®: https://hubs.la/Q043RCwc0

03/03/2026

04/11/2025

This describes the therapeutic success in managing a 56-year-old man presenting with symptomatic mid-cavitary obstruction, a variant of , through the combined administration of and . https://www.jacc.org/doi/10.1016/j.jaccas.2025.105433?utm_medium=social&utm_source=social_post&utm_campaign=social_post

16/09/2025

Vi aspettiamo questo Venerdì 19 Settembre alle ore 21.00 a S. Stefano a Modigliana per ascoltare un concerto di musica barocca organizzato dall Academia degli Incamminati di Modigliana.

27/06/2025

State-of-the-art analysis of electrocardiogram findings in sudden cardiac death https://bit.ly/3ZgUTzQ

31/05/2025

Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review - https://bit.ly/4iELU2H

31/05/2025

ACC’s now offers a 🆕 patient-facing infographic with information about C-reactive protein (CRP) as an additional cardiovascular risk factor to consider. The infographic includes a simple description of CRP as a marker of inflammation – a known driver of , how it is measured, what different CRP levels mean, and steps patients can take to address elevated CRP and support their heart health.

Download the infographic and learn more: https://bit.ly/3H9coMo